Cart
sales@molnova.com
BDZ-g
CAS No. 732278-52-3
BDZ-g( —— )
Catalog No. M35613 CAS No. 732278-52-3
BDZ-g is a potent and selective antagonist of AMPA receptor. BDZ-g can be used for the research of various neurological disorders involving excessive activity of AMPA receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 178 | In Stock |
|
| 5MG | 255 | In Stock |
|
| 10MG | 374 | In Stock |
|
| 25MG | 545 | In Stock |
|
| 50MG | 762 | In Stock |
|
| 100MG | 1017 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBDZ-g
-
NoteResearch use only, not for human use.
-
Brief DescriptionBDZ-g is a potent and selective antagonist of AMPA receptor. BDZ-g can be used for the research of various neurological disorders involving excessive activity of AMPA receptors.
-
DescriptionBDZ-g is a potent, selective antagonist of AMPA receptor. BDZ-g has the potential for the research of various neurological disorders involving excessive activity of AMPA receptors.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetiGluR
-
RecptoriGluR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number732278-52-3
-
Formula Weight407.49
-
Molecular FormulaC21H21N5O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1C=C(C=2C3=C(C=C4C(=C3)OCO4)C[C@@H](C)N(N2)C=5SC(C)=NN5)C=CC1N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang C, et al. Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold. ACS Chem Neurosci. 2014;5(2):138-147.?
molnova catalog
related products
-
AMPA receptor modula...
AMPA receptor modulator-1 can be activated by glutamate, thereby modulating ion channels.
-
Rislenemdaz mesylate
Rislenemdaz (MK 0657;CERC 301) is a potent, orally bioavailable, brain‐penetrant, NR2B-selective NMDA receptor (GluN2B) antagonist with Ki and IC 50 of 8.1 nM and 3.6 nM respectively.
-
UK-240455
UK-240455 is a potent and selective N-methyl-D-aspartic acid (NMDA) glycine receptor antagonist with neuroprotective effects and improvements in motor function in Parkinson's disease models, making it a potential candidate for Parkinson's disease treatment.
